The board of directors of Prosten Health Holdings Limited announced that: Mr. Shi Liangsheng and Mr. Han Jun (each an executive Director), and Mr. Chen Weixi (a non-executive Director) and Mr. Poon Yan Wai, Mr. Xu Xiaoping and Mr. Lam Kwok Cheong (each an independent non-executive Director) have resigned as Directors with effect from 12 February 2018; Mr. Xu Zhigang has been re-designated from an executive Director to a non-executive Director with effect from 12 February 2018; and Each of Mr. Zhang Chunhua ("Mr. Zhang") and Ms. Zhang Chunping ("Ms. Zhang") has been appointed as an executive Director and each of Ms. Chan Mei Yan, Hidy ("Ms. Chan"), Mr. Kwan Chi Hong ("Mr. Kwan") and Ms. Lee Kwun Ling, May Jean ("Ms. Lee") has been appointed as an independent non-executive Director with effect from 12 February 2018. The Board announced that Mr. Xu Zhigang has resigned, and Mr. Zhang has been appointed as the chairman of the Board with effect from 12 February 2018. The Board further announced that following the change of Directors as set out above and with effect from 12 January 2018: Mr. Poon Yan Wai will cease to be the chairman, and Mr. Chen Weixi, Mr. Xu Xiaoping and Mr. Lam Kwok Cheong will cease to be the members of the audit committee of the Company (the "Audit Committee").

Ms. Chan will be the chairman, and Mr. Kwan and Ms. Lee will be the members of the Audit Committee. Mr. Xu Xiaoping will cease to be the chairman, and Mr. Lam Kwok Cheong and Mr. Xu Zhigang will cease to be the members of the remuneration committee of the Company. Mr. Kwan will be the chairman, and Ms. Lee and Ms. Zhang will be the members of the Remuneration Committee; and Mr. Xu Zhigang will cease to be the chairman, and Mr. Lam Kwok Cheong and Mr. Xu Xiaoping will cease to be the members of the nomination committee of the Company.

Ms. Lee will be the chairman, and Ms. Chan and Ms. Zhang will be the members of the Nomination Committee. Ms. Wu Weilan has resigned as the company secretary and an authorised representative of the Company and Mr. Chan Koon Fat has been appointed as the new company secretary, a new authorised representative and the chief financial officer of the Company with effect from 12 February 2018. Following the respective resignation of Ms. Wu, the Board announced that Mr. Chan Koon Fat ("Mr. Chan") has been appointed as the chief financial officer of the Company, Company Secretary and the Authorised Representative of the Company under Rule 5.24 of the GEM Listing Rules with effect from 12 February 2018.